arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

BillionToOne, Inc.

BLLN Health Care Medical Specialities
$129.24
Today
as of Jul 22, 16:46 ET
Last 30 days +24.33% Jun 15 → Jul 22
$96.73 $106.34 $115.95 $125.57 $135.18 Jun 15 Jun 23 Jun 30 Jul 08 Jul 15 Jul 22
Open
$103.58
High
$106.21
Low
$96.21
Volume
$878,779
Avg Vol
$379,927
Mkt Cap
$5.8B
P/E (TTM)
—
Beta
—
52w High
$138.70
52w Low
$61.96
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 13 items

Jul 21 · 07:27 MT Newswires
BillionToOne Insider Sold Shares Worth $1,821,628, According to a Recent SEC Filing
Jul 20 · 13:00 PR PR Newswire
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
Jul 15 · 20:49 MT Newswires
Billiontoone Insider Sold Shares Worth $2,497,698, According to a Recent SEC Filing
▸ Show all 13 press releases & news Free account →

Overview

52-week range
$62
$139
88% of range
Avg surprise (last 1)
+3,300%
Avg reaction (last 1)
+1.9%
100% positive
Latest IV / EM
78%
EM ±17.8% · $130 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.47$-1.02$-0.56$-0.11$0.34 Actual $-1.47Actual $-0.39Actual $0.10Actual $0.34Est $0.01 SepMarSepMar/2026
Revenue vs Net Income Revenue Net income
$-15M$17M$49M$82M$114M Sep 24Mar 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $0.34 $0.01 +3,300% — +1.9% earnings
Tue Sep 30, 2025Sep 2025 $0.10 — — — — financials
Mon Mar 31, 2025Mar 2025 $-0.39 — — — — financials
Mon Sep 30, 2024Sep 2024 $-1.47 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 5, 2026Jun/2026AMC $0.15—

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Mar 2025Dec 2024Sep 2024
Revenue$108M—$84M$59M—$38M
Cost of revenue$29M—$25M$21M—$18M
Gross profit$79M—$58M$38M—$20M
Operating income$18M—$10M$-2M—$-13M
Net income$18M—$6M$-4M—$-15M
EPS (diluted)$0.34—$0.10$-0.39—$-1.47

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$537M$496M$195M—$191M—
Inventory$19M$18M$17M—$9M—
Total current assets$624M$561M$252M—$228M—
Total assets$701M$633M$328M—$302M—
Long-term debt——————
Total liabilities$195M$153M$148M—$134M—
Total equity$506M$480M$-240M$-253M$-252M$-243M

Implied volatility — last 90 days

54%70%86%102%118% Jun 07 — IV 84% · EM ±11.6%Jun 08 — IV 92% · EM ±12.2%Jun 09 — IV 95% · EM ±11.9%Jun 10 — IV 89% · EM ±10.5%Jun 11 — IV 88% · EM ±9.7%Jun 12 — IV 90% · EM ±9.2%Jun 15 — IV 88% · EM ±6.3%Jun 16 — IV 106% · EM ±6.2%Jun 17 — IV 119% · EM ±5.0%Jun 19 — IV 74% · EM ±16.5%Jun 22 — IV 77% · EM ±16.0%Jun 23 — IV 75% · EM ±15.2%Jun 24 — IV 76% · EM ±15.1%Jun 25 — IV 72% · EM ±14.1%Jun 26 — IV 75% · EM ±14.4%Jun 29 — IV 78% · EM ±13.8%Jun 30 — IV 72% · EM ±12.5%Jul 01 — IV 76% · EM ±12.7%Jul 02 — IV 73% · EM ±11.8%Jul 03 — IV 75% · EM ±11.7%Jul 06 — IV 75% · EM ±10.3%Jul 07 — IV 81% · EM ±10.7%Jul 08 — IV 84% · EM ±10.6%Jul 09 — IV 76% · EM ±8.9%Jul 10 — IV 77% · EM ±8.6%Jul 13 — IV 90% · EM ±7.5%Jul 14 — IV 79% · EM ±5.7%Jul 15 — IV 54% · EM ±3.2%Jul 16 — IV 90% · EM ±3.8%Jul 20 — IV 83% · EM ±19.6%Jul 21 — IV 79% · EM ±18.3%Jul 22 — IV 78% · EM ±17.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in